May 9 (Bloomberg) -- Hospira Inc., a maker of acute-care products, sued a U.S. unit of Germany’s B. Braun Melsungen AG alleging infringement of patents for drug-infusion pump technology.
B. Braun Medical Inc., based in Bethlehem, Pennsylvania, is using inventions that belong to Hospira, of Lake Forest, Illinois, by making and selling its drug-delivery systems without permission, Hospira contends in a complaint filed yesterday in federal court in Wilmington, Delaware.
“Hospira is the owner of the entire right, title and interest” in the patents, and Braun should pay damages for lost profits and legal fees and be prohibited from its wrongful actions after a jury trial, plaintiff’s lawyers said in court papers.
Hospira itself was sued in New York Federal court in February over a canceled influenza-vaccine supply contract by GlaxoSmithKline Plc., which questioned the quality of the product. The case is continuing.
Jason Ford, a B. Braun spokesman, didn’t immediately reply to voice and e-mail requests for comment on the patent action.
The case is Hospira Inc. v. B. Braun Medical Inc., 13-cv-00819, U.S. District Court, District of Delaware (Wilmington).
To contact the reporter on this story: Phil Milford in Wilmington, Delaware, at firstname.lastname@example.org.
To contact the editor responsible for this story: Michael Hytha at email@example.com.